Latuda
These highlights do not include all the information needed to use LATUDA safely and effectively. See full prescribing information for LATUDA. LATUDA (lurasidone hydrochloride) tablets, for oral use Initial U.S. Approval: 2010
afad3051-9df2-4c54-9684-e8262a133af8
HUMAN PRESCRIPTION DRUG LABEL
Jul 21, 2023
Sumitomo Pharma America, Inc.
DUNS: 131661746
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
lurasidone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
lurasidone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
lurasidone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
lurasidone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
lurasidone hydrochloride
Product Details
FDA regulatory identification and product classification information